VinVital

Asset

Adipose-derived mesenchymal stem cell secretome providing paracrine factors to improve regenerative capacity and function

Stage: Phase 1
Modality: Protein or enzyme
Target: Inflammation; 2
Indications: 1
Trial: 1
Developer

Indications

2

Aging
Phase 1, Not yet recruiting, NCT07856602, clinicaltrials.gov, 7 Oct 2026
Frailty syndrome
Phase 1, Not yet recruiting, NCT07856602, clinicaltrials.gov, 7 Oct 2026

In the full profile

Targets and what it contains2
Owner and partners2
Trials1
Evidence for its targets2
Competitors1
Aging relevance2
Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

Updated 7 Oct 2026, 1 source